{"id":"https://genegraph.clinicalgenome.org/r/e7084e4c-eab3-4298-bf42-14476269f92ev1.1","type":"EvidenceStrengthAssertion","dc:description":["HCN4-sinus node dysfunction with or without hypertrabeculation phenotype-autosomal dominant \n\nHCN4 encodes hyperpolarization-activated cyclic nucleotide channel 4 subunits, which form an ion channel that plays a key role in cardiac rhythmicity as a major constituent of the hyperpolarisation-activated “funny” current (If) in the sinoatrial node, also known as the spontaneous cardiac pacemaker. Genetic variation in HCN4 was first described by Schulze-Bahr (PMID 12750403) in 2003 in a patient with sinus node dysfunction (SND). In 2014 Schweizer et al. (PMID 25145518) and Milano et al (PMID 25145517) separately reported families in which genetic variation within HCN4 segregated with the combined SND and ventricular hypertrabeculation phenotype.\n \nAt least 25 unique variants have been reported to cause SND, primarily sinus bradycardia (PMIDs 12750403,  25145518, 25145517, 16407510, 35257104, 26688388, 23178648, 34088380,  31731876, 32600061, 28104484, 20662977, 16407510, 26206080, 32577394, 17646576, 35328031, 30471092, 33082984, 29440115, 15123648, 36244448). Fifteen publications report variants as the likely aetiology of both SND and ventricular hypertrabeculation (PMIDs 25145518, 25145517, 33008772, 35257104, 26688388, 34088380, 31731876, 32600061, 28104484, 26206080, 32577394, 35328031, 30471092, 33082984, 29440115).\n \nThe phenotypes of SND and ventricular hypertrabeculation were lumped as per criteria outlined by the ClinGen Lumping and Splitting Working Group (no differences in molecular mechanism, or inheritance pattern were identified). The mechanism of pathogenicity appears to be primarily one of loss of function (PMID 25145518). Segregation data support an autosomal dominant inheritance pattern (PMID 16407510). Genetic variants resulting in SND, and ventricular hypertrabeculation are predominately non-truncating, and reside within the transmembrane region (residues 267-517). The significance of genetic variation located outside of the transmembrane region remains unclear (PMID 33500567). Genetic hotspots exist within the conserved pore-forming region (nucleotide residues 465-486).\n \nThe association between HCN4 and SND with or without ventricular hypertrabeculation, is supported by both genetic and experimental evidence. The maximum score for genetic evidence (12 points) has been reached through review of case-level data, extensive family segregation and case-control data (variant burden analysis PMID 33500567; GWAS highlighting HCN4 as a modulator of heart rate PMID 23583979; case level and segregation data listed in publications above).\n \nExperimental evidence supporting the disease-gene association includes functional alteration data (PMIDs 33008772, 28104484, 25145517, 17646576, 25145517,  25145518, 12750403, 15123648, 23178648, 24607718, 16407510, 36244448), pharmacological targets (ivabradine-induced bradycardia), protein interaction data (STRING database) and multiple animal models demonstrating sinus node dysfunction with HCN4 knockout (PMID 17914461; PMID 18219271). \n \nStudies of individuals with specific variants located within the HCN4 pore-forming domain (p.Tyr481His, p.Gly482Arg, and p.Arg483_Val487del) support an association between HCN4 and thoracic aortic aneurysms (PMIDs 27173043, 31731876, 33185997, 35257104, 32577394). Additionally, genetic variation in HCN4 has also been associated with early onset atrial fibrillation (PMID 24607718s, 23178648, 28104484, 12750403), left atrial dilatation (PMID 33008772), mitral valve prolapse (PMIDs 26206080, 27173043, 25145518), atrioventricular block (PMID 36381173), ventricular tachycardia (PMID 36244448), ventricular fibrillation (PMIDs 36381173, 29440115), and tachycardia-induced cardiomyopathy (PMID 29987112). Further data is required to assess the strength of these gene-disease-gene associations.\n \nIn summary, HCN4 is definitively associated with autosomal dominant sinus node dysfunction with or without ventricular hypertrabeculation. This classification was approved by the ClinGen Hereditary Cardiovascular Disease GCEP on 22/10/24 (SOP version 11).\n","HCN4-sinus node dysfunction with or without hypertrabeculation phenotype-autosomal dominant \n\nHCN4 encodes hyperpolarization-activated cyclic nucleotide channel 4 subunits, which form an ion channel that plays a key role in cardiac rhythmicity as a major constituent of the hyperpolarisation-activated “funny” current (If) in the sinoatrial node, also known as the spontaneous cardiac pacemaker. Genetic variation in HCN4 was first described by Schulze-Bahr (PMID 12750403) in 2003 in a patient with sinus node dysfunction (SND). In 2014 Schweizer et al. (PMID 25145518) and Milano et al (PMID 25145517) separately reported families in which genetic variation within HCN4 segregated with the combined SND and ventricular hypertrabeculation phenotype.\n \nAt least 25 unique variants have been reported to cause SND, primarily sinus bradycardia (PMIDs 12750403,  25145518, 25145517, 16407510, 35257104, 26688388, 23178648, 34088380,  31731876, 32600061, 28104484, 20662977, 16407510, 26206080, 32577394, 17646576, 35328031, 30471092, 33082984, 29440115, 15123648, 36244448). Fifteen publications report variants as the likely aetiology of both SND and ventricular hypertrabeculation (PMIDs 25145518, 25145517, 33008772, 35257104, 26688388, 34088380, 31731876, 32600061, 28104484, 26206080, 32577394, 35328031, 30471092, 33082984, 29440115).\n \nThe phenotypes of SND and ventricular hypertrabeculation were lumped as per criteria outlined by the ClinGen Lumping and Splitting Working Group (no differences in molecular mechanism, or inheritance pattern were identified). The mechanism of pathogenicity appears to be primarily one of loss of function (PMID 25145518). Segregation data support an autosomal dominant inheritance pattern (PMID 16407510). Genetic variants resulting in SND, and ventricular hypertrabeculation are predominately non-truncating, and reside within the transmembrane region (residues 267-517). The significance of genetic variation located outside of the transmembrane region remains unclear (PMID 33500567). Genetic hotspots exist within the conserved pore-forming region (amino acid residues 465-486).\n \nThe association between HCN4 and SND with or without ventricular hypertrabeculation, is supported by both genetic and experimental evidence. The maximum score for genetic evidence (12 points) has been reached through review of case-level data, extensive family segregation and case-control data (variant burden analysis PMID 33500567; GWAS highlighting HCN4 as a modulator of heart rate PMID 23583979; case level and segregation data listed in publications above).\n \nExperimental evidence supporting the disease-gene association includes functional alteration data (PMIDs 33008772, 28104484, 25145517, 17646576, 25145517,  25145518, 12750403, 15123648, 23178648, 24607718, 16407510, 36244448), pharmacological targets (ivabradine-induced bradycardia), protein interaction data (STRING database) and multiple animal models demonstrating sinus node dysfunction with HCN4 knockout (PMID 17914461; PMID 18219271). \n \nStudies of individuals with specific variants located within the HCN4 pore-forming domain (p.Tyr481His, p.Gly482Arg, and p.Arg483_Val487del) support an association between HCN4 and thoracic aortic aneurysms (PMIDs 27173043, 31731876, 33185997, 35257104, 32577394). Additionally, genetic variation in HCN4 has also been associated with early onset atrial fibrillation (PMID 24607718s, 23178648, 28104484, 12750403), left atrial dilatation (PMID 33008772), mitral valve prolapse (PMIDs 26206080, 27173043, 25145518), atrioventricular block (PMID 36381173), ventricular tachycardia (PMID 36244448), ventricular fibrillation (PMIDs 36381173, 29440115), and tachycardia-induced cardiomyopathy (PMID 29987112). Further data is required to assess the strength of these gene-disease-gene associations.\n \nIn summary, HCN4 is definitively associated with autosomal dominant sinus node dysfunction with or without ventricular hypertrabeculation. This classification was approved by the ClinGen Hereditary Cardiovascular Disease GCEP on 22/10/24 (SOP version 11).\n"],"dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/e7084e4c-eab3-4298-bf42-14476269f92e","GCISnapshot":"https://genegraph.clinicalgenome.org/r/5c7f333b-2a94-42e9-a50e-b19240c3ccaf","calculatedEvidenceStrength":"Definitive","changes":{"id":"cg:summaryChange"},"contributions":[{"id":"https://genegraph.clinicalgenome.org/r/5c7f333b-2a94-42e9-a50e-b19240c3ccaf_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10104","date":"2025-08-21T16:27:18.507Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/5c7f333b-2a94-42e9-a50e-b19240c3ccaf_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10104","date":["2025-06-25T02:00:00.000Z","2025-06-24T04:00:00.000Z"],"role":"Approver"}],"curationReasons":["ErrorClarification"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5c7f333b-2a94-42e9-a50e-b19240c3ccaf_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5c7f333b-2a94-42e9-a50e-b19240c3ccaf_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d3cb0d93-7275-4e9c-be72-93d226e1f9aa","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/989fb15b-15ec-44b2-8c6c-0e2a996393f7","type":"Finding","dc:description":"RT-PCR analysis of human cardiovascular multiple tissue cDNAs as template was\nperformed with primer pairs specific to human HCN4. Size of the\nRT-PCR product was 233 bp. Relative density of PCR fragments from\neach tissue was measured as compared with that from an atrioventricular node (lane 12). Lane 1, adult heart; lane 2, fetal heart; lane 3, aorta;\nlane 4, apex of the left ventricle; lane 5, left atrium; lane 6, right atrium;\nlane 7, right auricle; lane 8, left auricle; lane 9, left ventricle; lane 10,\nright ventricle; lane 11, interventricular septum; and lane 12, atrioventricular node.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15123648","rdfs:label":"Ueda_Expression","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/84a681ce-e189-4db3-abe1-eac8f2c49cd1","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7543e395-9c41-48e5-ba8b-838261098406","type":"Finding","dc:description":"Gtex database shows that HCN4 is highly expressed in the heart","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23715323","rdfs:label":"Gtex_Expression","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/5c7f333b-2a94-42e9-a50e-b19240c3ccaf_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/79abe1d4-5183-49c8-9d7d-e8ea157c0ced","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5ae261f3-f92b-4fc3-9645-fe54adba42a1","type":"Finding","dc:description":"In vitro expression data strongly support the\nnotion that the patient suffered from SND due to the\nexpression of mutant HCN4 channels, which are\ninsensitive to intracellular cAMP and have altered\nactivation and deactivation properties.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12750403","rdfs:label":"Pacemaker channel dysfunction","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityCellCultureModelOrganismCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/dfca1140-2124-4f30-bc9a-ccb31b433d6f","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5cc8ebe1-f425-440b-90ec-520bca12ed21","type":"Finding","dc:description":"Phenotype observed in zebrafish hcn4 morphants was strikingly similar to that observed in humans SSS, and included bradycardia and prolonged sinus pauses","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28803248","rdfs:label":"Jou et al","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/3215d0fa-5397-4589-abba-107b3bec1ce8","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7456ac60-f96f-4c92-8105-d105b30238d0","type":"Finding","dc:description":"HCN4 induced loss of function mechanism in mice resulted in severe bradycardia and conduction disease, both of which are directly relatable to the sinus bradycardia and conduction disease seen in human patients with HCN4 variants.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21220308","rdfs:label":"Inducible bradycardia and heart block","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":5},{"id":"https://genegraph.clinicalgenome.org/r/5c7f333b-2a94-42e9-a50e-b19240c3ccaf_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ee6b2a56-2a74-4a64-acd1-e55cddbedace","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ee6b2a56-2a74-4a64-acd1-e55cddbedace_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26688388","allele":{"id":"https://genegraph.clinicalgenome.org/r/5067cf2e-2386-4889-b44c-f0fa2adb9601","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005477.3(HCN4):c.1123C>T (p.Arg375Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA7649363"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/ee6b2a56-2a74-4a64-acd1-e55cddbedace_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"EP studies (patch in Chinese hamster ovary cells) – reduced amplitude and densities of HCN4 current\n","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/1acefb2d-d444-43a3-b5dc-6cc7f0ca76ad","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1acefb2d-d444-43a3-b5dc-6cc7f0ca76ad_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25145517","allele":{"id":"https://genegraph.clinicalgenome.org/r/3cff04c8-a982-4a79-b364-e59d00c787db","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005477.3(HCN4):c.1441T>C (p.Tyr481His)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA16043943"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/1acefb2d-d444-43a3-b5dc-6cc7f0ca76ad_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Patch clamp analysis revealed a large negative shift of the voltage dependence of activation compared with the expression of only WT channels.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/35e2692f-39a4-40b1-af51-8692dcf9064d","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/35e2692f-39a4-40b1-af51-8692dcf9064d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26206080","allele":{"id":"https://genegraph.clinicalgenome.org/r/13a4fab7-59cf-461a-b4f2-af92dd584867","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005477.3(HCN4):c.1444G>A (p.Gly482Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA202778"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/f87a9347-fb04-4951-8a6b-c8270856465f","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f87a9347-fb04-4951-8a6b-c8270856465f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35257104","allele":{"id":"https://genegraph.clinicalgenome.org/r/13a4fab7-59cf-461a-b4f2-af92dd584867"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/fef2e503-89e6-4a7e-9d66-940330b145f4","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fef2e503-89e6-4a7e-9d66-940330b145f4_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30471092","allele":{"id":"https://genegraph.clinicalgenome.org/r/0fb08d6e-5f3d-4b6d-af59-618753b1fffd","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005477.3(HCN4):c.1403C>T (p.Ala468Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA7649297"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/c46c8c5e-76e0-4379-a381-d7f91aefc34a","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c46c8c5e-76e0-4379-a381-d7f91aefc34a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23178648","allele":{"id":"https://genegraph.clinicalgenome.org/r/7e910a3d-0bb6-4f40-af37-25f07f16548b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005477.3(HCN4):c.1590G>C (p.Lys530Asn)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA393093311"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/c46c8c5e-76e0-4379-a381-d7f91aefc34a_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Whole-cell patch clamp HEK293 cells: mutant heteromeric channels displayed a significant hyperpolarizing shift in the half-maximal activation voltage.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/6f2cd7c4-5a33-4e8c-9ba3-1b7e7f99d5f5","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6f2cd7c4-5a33-4e8c-9ba3-1b7e7f99d5f5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35328031","allele":{"id":"https://genegraph.clinicalgenome.org/r/539765f0-4515-42bc-9369-0168d103e208","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005477.3(HCN4):c.1438G>C (p.Gly480Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA117313"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/6f2cd7c4-5a33-4e8c-9ba3-1b7e7f99d5f5_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"PMID 17646576 - functional studies in xenopus oocytes and HEK293 cells demonstrating change in threshold for channel activation, slower inward current and a reduction in mutant protein expression compared with wild-type oocytes.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/a0800f5d-7571-4e93-94fd-7ce95367d631","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a0800f5d-7571-4e93-94fd-7ce95367d631_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29349559","allele":{"id":"https://genegraph.clinicalgenome.org/r/f81515da-c81e-4426-bc3d-2b78b749c601","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005477.3(HCN4):c.1438G>A (p.Gly480Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA393093935"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/af079b47-4bae-4b81-8f27-2ea7b5948166","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/af079b47-4bae-4b81-8f27-2ea7b5948166_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28104484","allele":{"id":"https://genegraph.clinicalgenome.org/r/07793922-8fec-4502-be8e-4a4e8de3f994","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005477.3(HCN4):c.1178G>A (p.Arg393His)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA301960"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/af079b47-4bae-4b81-8f27-2ea7b5948166_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Cells transfected with R393H mutant plasmids showed markedly reduced pacemaker currents and moderately reduced current density","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/fd3e26f3-7dc5-4c14-8b1b-52abb5114bd8","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fd3e26f3-7dc5-4c14-8b1b-52abb5114bd8_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32577394","allele":{"id":"https://genegraph.clinicalgenome.org/r/13a4fab7-59cf-461a-b4f2-af92dd584867"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/c18cf902-7075-455b-8eef-69e0c82a8c4c","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c18cf902-7075-455b-8eef-69e0c82a8c4c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28104484","allele":{"id":"https://genegraph.clinicalgenome.org/r/13a4fab7-59cf-461a-b4f2-af92dd584867"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/c18cf902-7075-455b-8eef-69e0c82a8c4c_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Shown to abolish pacemaker currents with a hyperpolarisation shift in voltage dependence of activation","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/2dc86071-ea65-4631-94ab-37dd7ae36c74","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2dc86071-ea65-4631-94ab-37dd7ae36c74_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23861362","allele":{"id":"https://genegraph.clinicalgenome.org/r/ca4d83f7-c24e-44b5-8dc3-e96e7e91aa91","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005477.3(HCN4):c.1209+2_1209+3insGAGT","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA199791"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/2dc86071-ea65-4631-94ab-37dd7ae36c74_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"From PMID 19165230: The possible functional alteration owing to the splice donor site mutation was investigated by using a transfection experiment with artificial minigene constructs. PCR fragments containing the splicing junction of wild type (WT) and the variant were transfected into COS7 cells. The mutated construct was found to generate an additional RT-PCR product not present in cells transfected with the WT construct suggesting that the additional 4 bases after the natural splice donor site were incorporated into mRNA. ","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/8e9f2e35-a033-4973-9b0a-e0f14060a514","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8e9f2e35-a033-4973-9b0a-e0f14060a514_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27173043","allele":{"id":"https://genegraph.clinicalgenome.org/r/3cff04c8-a982-4a79-b364-e59d00c787db"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/130b246f-cc46-4447-adf1-bb79c6328904","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/130b246f-cc46-4447-adf1-bb79c6328904_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30471092","allele":{"id":"https://genegraph.clinicalgenome.org/r/63cd0ea2-9e02-4bc8-92a2-a931d85eea6e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005477.3(HCN4):c.1438G>T (p.Gly480Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA393093937"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/649ba50b-b5b2-48df-bee5-2edea790f3e0","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/649ba50b-b5b2-48df-bee5-2edea790f3e0_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25145517","allele":{"id":"https://genegraph.clinicalgenome.org/r/3cff04c8-a982-4a79-b364-e59d00c787db"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/378082c0-e729-407a-a231-5bcc0de17fe6","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/378082c0-e729-407a-a231-5bcc0de17fe6_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31731876","allele":{"id":"https://genegraph.clinicalgenome.org/r/13a4fab7-59cf-461a-b4f2-af92dd584867"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/55a7eac1-1a8a-4ea4-ab7d-caae1305bba6","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/55a7eac1-1a8a-4ea4-ab7d-caae1305bba6_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31731876","allele":{"id":"https://genegraph.clinicalgenome.org/r/dfbc650f-2fee-47b3-8dee-1c141b5406e4","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005477.3(HCN4):c.1915G>A (p.Val639Met)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA246701"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/8ca6c1b4-778c-48f1-8526-1593767fccd0","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8ca6c1b4-778c-48f1-8526-1593767fccd0_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25145518","allele":{"id":"https://genegraph.clinicalgenome.org/r/13a4fab7-59cf-461a-b4f2-af92dd584867"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/8ca6c1b4-778c-48f1-8526-1593767fccd0_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Whole-cell patch clamping in HEK293 mutant cells. Mutant HCN4-G482R subunits did not produce relevant hyperpolarization activated inward currents, reflecting loss-of-function. ","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/5c7f333b-2a94-42e9-a50e-b19240c3ccaf_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/89d964ee-9fb7-4e14-8ef2-bba338e6a525_family_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16407510","rdfs:label":"Milanesi_S672R","family":{"id":"https://genegraph.clinicalgenome.org/r/89d964ee-9fb7-4e14-8ef2-bba338e6a525","type":"Family","rdfs:label":"Milanesi_S672R","ethnicity":{"id":"cg:UnknownEthnicity"}},"phenotype":{"id":"obo:HP_0001688"},"phenotypePositiveAllelePositive":27},{"id":"https://genegraph.clinicalgenome.org/r/67b55341-e124-493f-9fda-b054e39c22bb_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33008772","rdfs:label":"Alonso-Fernandez","estimatedLodScore":3.31,"family":{"id":"https://genegraph.clinicalgenome.org/r/67b55341-e124-493f-9fda-b054e39c22bb","type":"Family","rdfs:label":"Alonso-Fernandez","ethnicity":{"id":"cg:UnknownEthnicity"},"member":{"id":"https://genegraph.clinicalgenome.org/r/62e42d98-1d16-4e15-94fd-4265c2833a39","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33008772","rdfs:label":"III.I9","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":18,"allele":{"id":"https://genegraph.clinicalgenome.org/r/5067cf2e-2386-4889-b44c-f0fa2adb9601"},"phenotypes":["obo:HP_0030682","obo:HP_0011704"],"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/5e9ce633-5708-4b61-a700-a39d3076dd3e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33008772","allele":{"id":"https://genegraph.clinicalgenome.org/r/5067cf2e-2386-4889-b44c-f0fa2adb9601"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":12,"phenotypes":["obo:HP_0030682","obo:HP_0001688","obo:HP_0031295"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/62e42d98-1d16-4e15-94fd-4265c2833a39"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/834f4913-fae1-4b34-bf57-e6cf713e20e8_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30471092","rdfs:label":"Richard_2","family":{"id":"https://genegraph.clinicalgenome.org/r/834f4913-fae1-4b34-bf57-e6cf713e20e8","type":"Family","rdfs:label":"Richard_2","ethnicity":{"id":"cg:UnknownEthnicity"},"member":{"id":"https://genegraph.clinicalgenome.org/r/dd527f97-65f8-4579-857b-14bc1728c9e7","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30471092","rdfs:label":"3","allele":{"id":"https://genegraph.clinicalgenome.org/r/63cd0ea2-9e02-4bc8-92a2-a931d85eea6e"},"phenotypes":["obo:HP_0001688","obo:HP_0030682"],"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/130b246f-cc46-4447-adf1-bb79c6328904_variant_evidence_item"}}},"phenotypePositiveAllelePositive":3,"phenotypes":["obo:HP_0001688","obo:HP_0030682"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/dd527f97-65f8-4579-857b-14bc1728c9e7"}},{"id":"https://genegraph.clinicalgenome.org/r/993207f2-c843-48b6-a334-0ad318be117e_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25145518","rdfs:label":"Schweizer_FamilyB","estimatedLodScore":1.2,"family":{"id":"https://genegraph.clinicalgenome.org/r/993207f2-c843-48b6-a334-0ad318be117e","type":"Family","rdfs:label":"Schweizer_FamilyB","member":{"id":"https://genegraph.clinicalgenome.org/r/f62ca559-7e6c-450a-9397-b4b633c9819a","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25145518","rdfs:label":"Schweizer_FamilyB_II.3","allele":{"id":"https://genegraph.clinicalgenome.org/r/3751e1a1-fdbc-4780-ab08-e82cbb282fd8","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005477.3(HCN4):c.2083G>T (p.Glu695Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA393090053"}},"detectionMethod":"Direct exon sequencing of HCN4 ","firstTestingMethod":"Other","phenotypes":["obo:HP_0011704","obo:HP_0001688","obo:HP_0030682"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/7818c1bc-0919-4df3-9ace-1e110631c3bb_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25145518","allele":{"id":"https://genegraph.clinicalgenome.org/r/3751e1a1-fdbc-4780-ab08-e82cbb282fd8"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":4,"proband":{"id":"https://genegraph.clinicalgenome.org/r/f62ca559-7e6c-450a-9397-b4b633c9819a"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/b5f19fc0-ca51-401e-a2df-b87e07b059da_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26206080","rdfs:label":"Milat_1","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/b5f19fc0-ca51-401e-a2df-b87e07b059da","type":"Family","rdfs:label":"Milat_1","member":{"id":"https://genegraph.clinicalgenome.org/r/ad7da08e-0bf8-43a4-932c-175663b0f6b7","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26206080","rdfs:label":"Millat_A","allele":{"id":"https://genegraph.clinicalgenome.org/r/13a4fab7-59cf-461a-b4f2-af92dd584867"},"phenotypes":["obo:HP_0012727","obo:HP_0011704"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/35e2692f-39a4-40b1-af51-8692dcf9064d_variant_evidence_item"}}},"phenotypeFreeText":"Ascending aortic dilatation ","phenotypePositiveAllelePositive":3,"phenotypes":["obo:HP_0001688","obo:HP_0030682"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/ad7da08e-0bf8-43a4-932c-175663b0f6b7"}},{"id":"https://genegraph.clinicalgenome.org/r/f8c8c952-9240-4aba-8bcf-013bb8ae9517_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27173043","rdfs:label":"Vermeer_FamilyI","estimatedLodScore":1.81,"family":{"id":"https://genegraph.clinicalgenome.org/r/f8c8c952-9240-4aba-8bcf-013bb8ae9517","type":"Family","rdfs:label":"Vermeer_FamilyI","member":{"id":"https://genegraph.clinicalgenome.org/r/530ae74c-5dff-4765-9c00-c5feac8af596","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27173043","rdfs:label":"Vermeer I-IV:1","allele":{"id":"https://genegraph.clinicalgenome.org/r/3cff04c8-a982-4a79-b364-e59d00c787db"},"firstTestingMethod":"Next generation sequencing panels","phenotypes":["obo:HP_0011704","obo:HP_0001688","obo:HP_0030682","obo:HP_0012727"],"previousTesting":true,"previousTestingDescription":"SCN5A genotyping \nCardiac panel - 46 cardiomyopathy-associated genes\nAortic dilation panel - 15 associated genes associated genes ","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/8e9f2e35-a033-4973-9b0a-e0f14060a514_variant_evidence_item"}}},"meetsInclusionCriteria":true,"phenotypeFreeText":"7 members of the family presented with aortic dilation, in addition to a combined clinical phenotype of sinus bradycardia, noncompaction cardiomyopathy (NCCM), and mitral valve defects","phenotypePositiveAllelePositive":7,"proband":{"id":"https://genegraph.clinicalgenome.org/r/530ae74c-5dff-4765-9c00-c5feac8af596"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/180a2554-c76b-4137-818a-b70e2a184ef1","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/180a2554-c76b-4137-818a-b70e2a184ef1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25145517","allele":{"id":"https://genegraph.clinicalgenome.org/r/13a4fab7-59cf-461a-b4f2-af92dd584867"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/180a2554-c76b-4137-818a-b70e2a184ef1_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Patch clamp analysis revealed a large negative shift of the voltage dependence of activation compared with the expression of only WT channels. ","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/9565dabe-06e5-46af-ad35-48319f036f05","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9565dabe-06e5-46af-ad35-48319f036f05_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32577394","allele":{"id":"https://genegraph.clinicalgenome.org/r/109d229a-90e2-447f-baf3-f4b5fbc4a338","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005477.3(HCN4):c.1444G>C (p.Gly482Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA16043942"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/8fa834a0-3be7-43ec-85b7-ebf84eee55aa","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8fa834a0-3be7-43ec-85b7-ebf84eee55aa_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33082984","allele":{"id":"https://genegraph.clinicalgenome.org/r/f81515da-c81e-4426-bc3d-2b78b749c601"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/b057a9af-6dda-4812-9a68-a6e3171efd0c","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b057a9af-6dda-4812-9a68-a6e3171efd0c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35328031","allele":{"id":"https://genegraph.clinicalgenome.org/r/13a4fab7-59cf-461a-b4f2-af92dd584867"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/ed9626f5-0448-4a14-a1d6-9b9d8f75b54b","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ed9626f5-0448-4a14-a1d6-9b9d8f75b54b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33082984","allele":{"id":"https://genegraph.clinicalgenome.org/r/39da8789-ac06-4e94-b200-0a81f8b04697","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005477.3(HCN4):c.1454C>A (p.Ala485Glu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA393093869"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/a0dcdb8e-4832-49bf-bd00-20ecfe285b97","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a0dcdb8e-4832-49bf-bd00-20ecfe285b97_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26688388","allele":{"id":"https://genegraph.clinicalgenome.org/r/109d229a-90e2-447f-baf3-f4b5fbc4a338"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/a0dcdb8e-4832-49bf-bd00-20ecfe285b97_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"heterologous expression studies revealed a large negative shift of the voltage dependence of activation compared with that of wild-type. \n","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/07928ba4-9050-4730-8a1b-c2283e5baba6","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/07928ba4-9050-4730-8a1b-c2283e5baba6_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35328031","allele":{"id":"https://genegraph.clinicalgenome.org/r/0be6aea1-c717-4844-96b8-9045d318196f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005477.3(HCN4):c.1454C>T (p.Ala485Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA393093865"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/07928ba4-9050-4730-8a1b-c2283e5baba6_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Western blot revealing reduction in expression of HCN4 in HEK293 cells and large hyperpolarising shifts in the voltage dependence ","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/5e9ce633-5708-4b61-a700-a39d3076dd3e","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5e9ce633-5708-4b61-a700-a39d3076dd3e_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/5e9ce633-5708-4b61-a700-a39d3076dd3e_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"EP studies (patch in Chinese hamster ovary cells) – reduced amplitude and densities of HCN4 current\n","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/76ad4db2-3f9b-4cbe-8ce0-06e2fbd470f2","type":"EvidenceLine","dc:description":"The VAF does not support the pathogenicity of this variant.","calculatedScore":0.1,"direction":"Contradicts","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/76ad4db2-3f9b-4cbe-8ce0-06e2fbd470f2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25145518","allele":{"id":"https://genegraph.clinicalgenome.org/r/d99030e4-253b-49be-80a9-e7307607bb01","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005477.3(HCN4):c.2648C>G (p.Pro883Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA163178"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/7818c1bc-0919-4df3-9ace-1e110631c3bb","type":"EvidenceLine","dc:description":"\n","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7818c1bc-0919-4df3-9ace-1e110631c3bb_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/7785b713-8a7a-4f5e-ba36-f2f86b7652b5","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7785b713-8a7a-4f5e-ba36-f2f86b7652b5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15123648","allele":{"id":"https://genegraph.clinicalgenome.org/r/0d0ea6af-f91e-4d69-9f5f-a07601f0444e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005477.3(HCN4):c.1657G>A (p.Asp553Asn)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA117311"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/7785b713-8a7a-4f5e-ba36-f2f86b7652b5_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Reduction in membrane expression associated with reduced current amplitude - trafficking abnormality of D553N-defective channels","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/b4ec6102-8a2c-4913-abfb-8d5f73a864c2","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b4ec6102-8a2c-4913-abfb-8d5f73a864c2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31731876","allele":{"id":"https://genegraph.clinicalgenome.org/r/031c047c-19cc-4cfa-9377-ac00cddd0d0e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005477.3(HCN4):c.3197C>A (p.Pro1066His)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA247667"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/1f9e0688-33cb-4b13-9243-6880c7ca3230","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1f9e0688-33cb-4b13-9243-6880c7ca3230_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31731876","allele":{"id":"https://genegraph.clinicalgenome.org/r/dfbc650f-2fee-47b3-8dee-1c141b5406e4"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12}],"evidenceStrength":"Definitive","sequence":11355,"specifiedBy":"GeneValidityCriteria11","strengthScore":17,"subject":{"id":"https://genegraph.clinicalgenome.org/r/v9kEr1kDbGI","type":"GeneValidityProposition","disease":"obo:MONDO_0008102","gene":"hgnc:16882","modeOfInheritance":"obo:HP_0000006"},"version":"1.1","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_5c7f333b-2a94-42e9-a50e-b19240c3ccaf-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}